FDA falls short on foreign inspections

In another post, Blue Cross had opened up shop in China, so is there a chance for additional outsourcing here too with the recent contract agreement in place...BD 

WASHINGTON - The Food and Drug Administration is making progress in conducting more inspections of foreign drug manufacturers, but still inspects relatively few facilities.

The agency conducted 30 such inspections in the last fiscal year and plans to conduct at least 50 this year, according to government auditors.  Also, the agency plans to establish foreign offices in three Chinese locations — Beijing, Shanghai and Guangzhou. Later, it will consider setting up locations in India, the Middle East, Latin America and Europe.

Auditors: FDA falls short on foreign inspections - Health care- msnbc.com